BMP Pharma Trading AG (STU:BMP) Other Current Receivables: €8.04 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BMP BMP Pharma Trading AG STU:BMP
36 GF Score
Price €6.20
! 2 Warning Signs
View Full Analysis

What is BMP Pharma Trading AG Other Current Receivables?

BMP Pharma Trading AG STU:BMP 36 Other Current Receivables is €8.04 Mil as of Dec. 2025. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

BMP Pharma Trading AG's Other Current Receivables for the quarter that ended in Dec. 2025 was €8.04 Mil.

BMP Pharma Trading AG's quarterly Other Current Receivables declined from Dec. 2024 (€8.23 Mil) to Jun. 2025 (€0.00 Mil) but then increased from Jun. 2025 (€0.00 Mil) to Dec. 2025 (€8.04 Mil).

BMP Pharma Trading AG's annual Other Current Receivables increased from Dec. 2023 (€6.93 Mil) to Dec. 2024 (€8.23 Mil) but then declined from Dec. 2024 (€8.23 Mil) to Dec. 2025 (€8.04 Mil).

BMP Pharma Trading AG Other Current Receivables Related Terms

BMP Pharma Trading AG Other Current Receivables Historical Data

* Premium members only.

The historical data trend for BMP Pharma Trading AG's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BMP Pharma Trading AG Other Current Receivables Chart

BMP Pharma Trading AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.69 6.90 6.93 8.23 8.04

BMP Pharma Trading AG Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.93 0.00 8.23 0.00 8.04
STU:BMP
36GF Score
BMP Pharma Trading AG STU:BMP
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BMP Pharma Trading AG Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €8.04 Mil mean?
BMP Pharma Trading AG (STU:BMP) has a Other Current Receivables of €8.04 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on BMP Pharma Trading AG and its competitors.
Is BMP Pharma Trading AG's Other Current Receivables too high?
BMP Pharma Trading AG's current Other Current Receivables is €8.04 Mil. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's Other Current Receivables compare to MCK and COR?
BMP Pharma Trading AG's Other Current Receivables of €8.04 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Distribution company?
A good Other Current Receivables depends on the Medical Distribution industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on BMP Pharma Trading AG and its competitors. BMP Pharma Trading AG's current Other Current Receivables is €8.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current Other Current Receivables of €8.04 Mil. The current Other Current Receivables is €8.04 Mil. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current Other Current Receivables is €8.04 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BMP Pharma Trading AG Business Description

Address Bornbarch 16, Norderstedt, SH, DEU, 22848
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score

Get the complete analysis for STU:BMP

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.20
Price